Y020-3929 Screening compound: N-[4-(3-{6-fluoro-1H,2H,3H,4H,9H-pyrido[3,4-b]indol-2-yl}-2,5-dioxopyrrolidin-1-yl)phenyl]acetamide

Y020-3929 Screening compound: N-[4-(3-{6-fluoro-1H,2H,3H,4H,9H-pyrido[3,4-b]indol-2-yl}-2,5-dioxopyrrolidin-1-yl)phenyl]acetamide
Y020-3929 Screening compound: N-[4-(3-{6-fluoro-1H,2H,3H,4H,9H-pyrido[3,4-b]indol-2-yl}-2,5-dioxopyrrolidin-1-yl)phenyl]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound Y020-3929
N-[4-(3-{6-fluoro-1H,2H,3H,4H,9H-pyrido[3,4-b]indol-2-yl}-2,5-dioxopyrrolidin-1-yl)phenyl]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

Y020-3929

Molecular Formula

C23H21FN4O3 (C23 H21 FN4 O3)

Compound Name

N-[4-(3-{6-fluoro-1H,2H,3H,4H,9H-pyrido[3,4-b]indol-2-yl}-2,5-dioxopyrrolidin-1-yl)phenyl]acetamide

IUPAC name

N-[4-(3-{6-fluoro-1H2H3H4H9H-pyrido[34-b]indol-2-yl}-25-dioxopyrrolidin-1-yl)phenyl]acetamide

SMILES

CC(Nc(cc1)ccc1N(C(CC1N(CC2)Cc3c2c(cc(cc2)F)c2[nH]3)=O)C1=O)=O

InChI

InChI=1S/C23H21FN4O3/c1-13(29)25-15-3-5-16(6-4-15)28-22(30)11-21(23(28)31)27-9-8-17-18-10-14(24)2-7-19(18)26-20(17)12-27/h2-7,10,21,26H,8-9,11-12H2,1H3,(H,25,29)/t21-/m0/s1

InChI Key

GNBWBCRENPWLOY-NRFANRHFSA-N

MDL Number (MFCD)

MFCD12215438

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

420.44

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

0.940

Distribution Coefficient, logD

0.940

Water Solubility, LogSw

-2.23

Polar Surface Area

65.762

Acid Dissociation Constant (pKa)

12.73

Base Dissociation Constant (pKb)

2.08

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

26.10

Y020-3929 in Drug Discovery

Included in Screening Libraries

Anti-infective Library (19449 compounds)

Antiviral Library (67538 compounds)

DGK Inhibitors Library (10558 compounds)

Indole Derivatives (10091 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Immune system
  • animal
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Hemic and lymphatic
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Kinases
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with Y020-3929 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound Y020-3929?
Check Price and Availability of Y020-3929, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of Y020-3929 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for Y020-3929
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for Y020-3929
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of Y020-3929 available by request